Breaking The Cycle: A Dietary Approach To Modulating The Microbial-Immune Crosstalk In A Patient With Crohn’s And Autism

This case report examines the beneficial effects of a self-prescribed restricted diet (RD) on disease progression, gut microbiome composition, and systemic immune responses in a pediatric patient with Crohn's disease (CD) and autism.Over a two-year period of dietary intervention, the patient maintained sustained clinical remission (visits 1-4), followed by disease relapse upon reintroduction of a free diet (FD) at visit 5.The RD included selected animal products, cooked vegetables, fresh fruits, legumes, beans, and healthy fats, while excluding white bread, rice, pasta, cereal, fresh vegetables, caffeine, processed foods, milk, fast food, and fizzy drinks.During remission, longitudinal microbiome analysis revealed a progressive stabilization of gut microbial ecology, marked by a shift from the phylum Bacteroidota to the Firmicutes, mainly dominated by Lachnospiraceae and Bifidobacterium species.Similarly, the oral microbial profile showed an increase in the Firmicutes, notably Streptococcus thermophilus and Lactobacillus crispatus.The microbiome recovery paralleled the transcriptomic shifts, wherein gene expression profiles also began to normalize, particularly in pathways related to immune modulation and metabolic homeostasis.The blood transcriptome analysis at V3 showed a downregulation of pro-inflammatory biomarkers, reduced activity of macrophages versus an increased activity of T cells CD4+, CD8+, and Tregs.Metabolic and neurological pathway analysis revealed downregulation of insulin signaling and apoptosis alongside enhanced neurotransmission (dopamine, norepinephrine, serotonin) and gap junction assembly.Together, these patterns suggest that specific dietary regimens may promote clinical remission in CD symptoms by rebalancing the microbiome-immune cross-talks.The observed relapse upon cessation of the restricted diet underscores the potential role of personalized nutrition in disease management, warranting further investigation into microbiome-directed dietary therapies for CD-autistic patients.